These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 8685891)

  • 1. Disulfiram and diethyldithiocarbamate intoxication affects the storage and release of striatal dopamine.
    Vaccari A; Saba PL; Ruiu S; Collu M; Devoto P
    Toxicol Appl Pharmacol; 1996 Jul; 139(1):102-8. PubMed ID: 8685891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential mechanisms in the effects of disulfiram and diethyldithiocarbamate intoxication on striatal release and vesicular transport of glutamate.
    Vaccari A; Ferraro L; Saba P; Ruiu S; Mocci I; Antonelli T; Tanganelli S
    J Pharmacol Exp Ther; 1998 Jun; 285(3):961-7. PubMed ID: 9618395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
    Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of vesicular and cytosolic dopamine to the increased striatal dopamine efflux elicited by intrastriatal injection of dexamphetamine.
    Watanabe S; Aono Y; Fusa K; Takada K; Saigusa T; Koshikawa N; Cools AR
    Neuroscience; 2005; 136(1):251-7. PubMed ID: 16181742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lobeline and nicotine evoke [3H]overflow from rat striatal slices preloaded with [3H]dopamine: differential inhibition of synaptosomal and vesicular [3H]dopamine uptake.
    Teng L; Crooks PA; Sonsalla PK; Dwoskin LP
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1432-44. PubMed ID: 9067333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Styrene and styrene oxide affect the transport of dopamine in purified rat striatal synaptic vesicles.
    Chakrabarti SK
    Biochem Biophys Res Commun; 1999 Feb; 255(1):70-4. PubMed ID: 10082657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the mechanism of depletion of striatal dopamine by alpha-methyl-m-tyrosine.
    Uretsky NJ; Snodgrass SR; Lorenzo AV
    J Pharmacol Exp Ther; 1975 Dec; 195(3):465-79. PubMed ID: 490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semi-chronic increase in striatal level of 3,4-dihydroxyphenylacetaldehyde does not result in alteration of nigrostriatal dopaminergic neurones.
    Legros H; Janin F; Dourmap N; Bonnet JJ; Costentin J
    J Neurosci Res; 2004 Feb; 75(3):429-35. PubMed ID: 14743456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum.
    Biggs CS; Starr MS
    Synapse; 1999 Oct; 34(1):36-46. PubMed ID: 10459170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmitter release by non-receptor activation of the alpha-subunit of guanine nucleotide regulatory protein in rat striatal slices.
    Zelles T; Chernaeva L; Baranyi M; Déri Z; Adam-Vizi V; Vizi ES
    J Neurosci Res; 1995 Oct; 42(2):242-51. PubMed ID: 8568925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of vesicular and cytosolic dopamine to the increased striatal dopamine efflux elicited by intrastriatal injection of SKF38393.
    Saigusa T; Aono Y; Sekino R; Uchida T; Takada K; Oi Y; Koshikawa N; Cools AR
    Eur J Pharmacol; 2009 Dec; 624(1-3):10-5. PubMed ID: 19836368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylphenidate alters vesicular monoamine transport and prevents methamphetamine-induced dopaminergic deficits.
    Sandoval V; Riddle EL; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1181-7. PubMed ID: 12604695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine.
    Stone DM; Johnson M; Hanson GR; Gibb JW
    J Pharmacol Exp Ther; 1988 Oct; 247(1):79-87. PubMed ID: 2902215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The non-peptidic delta opioid receptor agonist TAN-67 enhances dopamine efflux in the nucleus accumbens of freely moving rats via a mechanism that involves both glutamate and free radicals.
    Fusa K; Takahashi I; Watanabe S; Aono Y; Ikeda H; Saigusa T; Nagase H; Suzuki T; Koshikawa N; Cools AR
    Neuroscience; 2005; 130(3):745-55. PubMed ID: 15590157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in reserpine-induced striatal dopamine output and content between female and male mice: implications for sex differences in vesicular monoamine transporter 2 function.
    Dluzen DE; Bhatt S; McDermott JL
    Neuroscience; 2008 Jul; 154(4):1488-96. PubMed ID: 18515015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bupropion increases striatal vesicular monoamine transport.
    Rau KS; Birdsall E; Hanson JE; Johnson-Davis KL; Carroll FI; Wilkins DG; Gibb JW; Hanson GR; Fleckenstein AE
    Neuropharmacology; 2005 Nov; 49(6):820-30. PubMed ID: 16005476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine modulating drugs influence striatal (+)-[11C]DTBZ binding in rats: VMAT2 binding is sensitive to changes in vesicular dopamine concentration.
    Tong J; Wilson AA; Boileau I; Houle S; Kish SJ
    Synapse; 2008 Nov; 62(11):873-6. PubMed ID: 18720517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-course of modifications elicited by reserpine on the density and mRNA synthesis of the vesicular monoamine transporter, and on the density of the membrane dopamine uptake complex.
    Naudon L; Leroux-Nicollet I; Raisman-Vozari R; Botton D; Costentin J
    Synapse; 1995 Sep; 21(1):29-36. PubMed ID: 8525459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D2 autoreceptors are not involved in the down-regulation of the striatal dopamine transporter caused by alpha-methyl-p-tyrosine.
    Han S; Rowell PP; Carr LA
    Res Commun Mol Pathol Pharmacol; 1999; 104(3):331-8. PubMed ID: 10741383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early changes in neuropeptide mRNA expression in the striatum following reserpine treatment.
    Harrison MB; Kumar S; Hubbard CA; Trugman JM
    Exp Neurol; 2001 Feb; 167(2):321-8. PubMed ID: 11161620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.